Physician profile
Shannon M Johnson
NPI 1710231261
$19,448.12
in general payments reported to CMS, 2019-2025
93 companies · $5,335 in 2025
The $5,335 reported for 2025 was more than what 98% of Adult Health (Nurse Practitioner) providers received nationally (typical 2025 total: $182).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $2,638 · 2022: $3,317 · 2023: $3,388 · 2024: $4,770 · 2025: $5,335.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $13K · Education: $914.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $12,579.63 |
| Education | $913.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Celgene Corporation | $1,621.51 | 2021-2025 | Pomalyst, Reblozyl, Opdualag |
| Janssen Biotech, INC. | $998.92 | 2021-2025 | Rybrevant, Darzalex, Erleada |
| Pfizer INC. | $884.54 | 2021-2025 | |
| Novartis Pharmaceuticals Corporation | $864.11 | 2021-2025 | Kisqali |
| Astrazeneca Pharmaceuticals Lp | $734.43 | 2021-2025 | Imfinzi, Tagrisso, Calquence |
| Amgen INC. | $720.44 | 2021-2023 | Blincyto, Kyprolis, Lumakras |
| Sobi, INC | $701.50 | 2022-2025 | |
| Abbvie INC. | $696.70 | 2021-2025 | |
| E.R. Squibb & Sons, L.L.C. | $552.25 | 2021-2025 | Opdivo, Opdualag |
| Glaxosmithkline, LLC. | $529.76 | 2021-2025 | Ojjaara, Zejula, Jemperli |
| Daiichi Sankyo INC. | $505.42 | 2021-2025 | Enhertu |
| Genzyme Corporation | $471.74 | 2021-2025 | |
| Incyte Corporation | $458.98 | 2021-2025 | Jakafi, Monjuvi, Niktimvo |
| Rigel Pharmaceuticals, INC. | $457.64 | 2021-2025 | Rezlidhia, Tavalisse, Gavreto |
| Aveo Pharmaceuticals, INC. | $456.30 | 2022-2025 | Fotivda |
Show all 93 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $437.07 | 2021-2025 | Jaypirca, Verzenio, Retevmo |
| Merck Sharp & Dohme LLC | $432.69 | 2021-2025 | Keytruda, Welireg, Reblozyl |
| Karyopharm Therapeutics INC. | $415.01 | 2021-2024 | Xpovio |
| Ipsen Biopharmaceuticals, INC | $373.35 | 2021-2025 | Onivyde, Tazverik |
| Astellas Pharma US INC | $351.93 | 2021-2025 | Xtandi, Padcev, Xospata |
| Boehringer Ingelheim Pharmaceuticals, INC. | $328.27 | 2021-2025 | Gilotrif |
| Pharmacyclics LLC, An Abbvie Company | $264.94 | 2022-2023 | Imbruvica, Epkinly |
| Alexion Pharmaceuticals, INC. | $258.00 | 2021-2025 | Soliris, Ultomiris |
| Jazz Pharmaceuticals INC. | $252.37 | 2022-2025 | |
| Pharmacosmos Therapeutics INC. | $251.12 | 2021-2025 | Monoferric |
| Genentech USA, INC. | $236.19 | 2022-2025 | Polivy, Rozlytrek, Alecensa |
| US Oncology Corporate, INC. | $232.87 | 2025 | |
| Adaptive Biotechnologies Corporation | $230.96 | 2022-2025 | Clonoseq |
| Puma Biotechnology, INC. | $223.36 | 2022-2025 | |
| Regeneron Healthcare Solutions, INC. | $217.84 | 2021-2025 | Libtayo |
| Blueprint Medicines Corporation | $215.76 | 2023-2024 | Ayvakit |
| Seagen INC. | $185.27 | 2021-2025 | Padcev |
| Boston Scientific Corporation | $184.12 | 2024-2025 | Therasphere Y90 Glass Microspheres 10 Gbq |
| Taiho Oncology, INC. | $180.60 | 2021-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $167.84 | 2021-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $152.84 | 2023-2025 | Ninlaro, Fruzaqla |
| Tersera Therapeutics LLC | $152.12 | 2024-2025 | Xermelo, Zoladex |
| Pharmaessentia USA Corporation | $150.63 | 2022-2025 | Besremi |
| Organon LLC | $148.31 | 2022-2023 | Ontruzant |
| Fennec Pharmaceuticals, INC. | $145.49 | 2024-2025 | Pedmark, Fyarro |
| Deciphera Pharmaceuticals INC. | $143.78 | 2021-2025 | Qinlock, Romvimza |
| Sirtex Medical INC | $141.57 | 2023-2025 | Sir-Spheres Microspheres |
| Recordati_rare_diseases_inc. | $131.48 | 2024-2025 | Sylvant, Enjaymo |
| Agios Pharmaceuticals, INC. | $108.46 | 2024-2025 | Pyrukynd |
| Array Biopharma INC | $108.09 | 2023-2025 | Braftovi, Mektovi, Lorbrena |
| Invivyd INC | $105.75 | 2025 | Pemgarda |
| Eisai INC. | $103.03 | 2024-2025 | |
| Johnson & Johnson Health Care Systems INC. | $101.43 | 2023 | Tremfya |
| Sanofi-Aventis U.S. LLC | $83.99 | 2025 | |
| Cti Biopharma Corp. | $83.20 | 2022-2023 | Vonjo |
| Myovant Sciences INC. | $76.31 | 2021 | |
| Emd Serono, INC. | $74.61 | 2021-2025 | |
| Dendreon Pharmaceuticals LLC | $63.29 | 2025 | Provenge |
| Kite Pharma, INC. | $62.75 | 2025 | Yescarta |
| Beigene USA, INC. | $61.03 | 2023 | Brukinsa |
| Pharming Healthcare, INC. | $60.38 | 2024-2025 | Ruconest |
| Novo Nordisk INC | $57.15 | 2024 | Rybelsus, Ozempic |
| Gilead Sciences, INC. | $53.98 | 2021-2022 | |
| Stemline Therapeutics INC. | $52.40 | 2025 | Orserdu |
| Servier Pharmaceuticals LLC | $50.48 | 2022 | |
| Morphosys, US INC. | $44.06 | 2021-2022 | |
| Springworks Therapeutics, INC. | $43.71 | 2024-2025 | Gomekli, Ogsiveo |
| Sun Pharmaceutical Industries INC. | $42.90 | 2022-2024 | |
| Azurity Pharmaceuticals, INC. | $42.65 | 2024-2025 | Danziten, Vivimusta |
| Sandoz INC. | $41.08 | 2021-2025 | |
| Genmab U.S., INC. | $39.81 | 2024 | Tivdak, Epkinly |
| Mirati Therapeutics, INC. | $37.36 | 2023-2024 | Krazati |
| Iovance Biotherapeutics, INC. | $36.95 | 2024 | Amtagvi |
| Adc Therapeutics America, INC. | $35.34 | 2024 | |
| Sumitomo Pharma America, INC. | $33.49 | 2023-2025 | Orgovyx |
| Teva Pharmaceuticals USA, INC. | $32.16 | 2021 | |
| Octapharma USA, INC. | $31.43 | 2023 | Cutaquig |
| Beone Medicines USA, INC. | $29.58 | 2025 | Tevimbra |
| Legend Biotech USA INC. | $29.50 | 2025 | Carvykti |
| Progenics Pharmaceuticals, INC. | $29.22 | 2022 | |
| Caris Mpi, INC. | $28.72 | 2025 | Mi Cancer Seek |
| Tempus Ai, INC | $26.71 | 2024 | Xt Cdx |
| Fresenius Kabi USA, LLC | $26.60 | 2025 | |
| Tolmar, INC. | $24.95 | 2023 | |
| G1 Therapeutics, INC. | $24.79 | 2022 | |
| Inspire Medical Systems, INC. | $24.65 | 2025 | Inspire |
| Janssen Pharmaceuticals, INC | $20.85 | 2021 | |
| Coherus Oncology, INC. | $17.09 | 2022 | |
| Ferring Pharmaceuticals INC. | $16.24 | 2025 | Adstiladrin |
| Inari Medical, INC. | $16.20 | 2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Foundation Medicine, INC. | $14.79 | 2021 | |
| Shorla Oncology INC. | $14.49 | 2025 | |
| Immunocore Limited | $14.30 | 2025 | Kimmtrak |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $14.07 | 2022 | |
| Aurinia Pharma U.S., INC. | $13.57 | 2025 | Lupkynis |
| Spectrum Pharmaceuticals INC. | $13.52 | 2023 | Rolvedon |
| Vapotherm INC | $12.06 | 2022 | |
| Pharmaand Gmbh | $8.93 | 2025 | Rubraca |
Drugs and devices associated with these payments
Pomalyst $521Enhertu $431Rybrevant $425Opdivo $384Imbruvica $359Epkinly $352Tavalisse $337Rezlidhia $337Ojjaara $334Vonjo $315Fotivda $304Keytruda $303Opdualag $284Sarclisa $280Ibrance $275Jaypirca $257Kisqali $244Ayvakit $240Zepzelca $237Verzenio $236Reblozyl $229Clonoseq $217Doptelet $186Xtandi $186Darzalex $185Therasphere Y90 Glass Microspheres 10 Gbq $184Libtayo $174Imfinzi $170Monoferric $167Welireg $165Gilotrif $158Venclexta $150Pluvicto $147Talzenna $145Sir-Spheres Microspheres $142Besremi $138Tukysa $134Erleada $130Xermelo $128Orgovyx $127Pedmark $124Jakafi $119Xpovio $117Polivy $116Akeega $114Mektovi $108Braftovi $108Pemgarda $106Sylvant $105Lenvima $103Tremfya $101Tagrisso $101Gavreto $99.28Sprycel $98.73Synagis $98.37Onivyde $93.99Talvey $86.03Soliris $85.00Nubeqa $84.98Lonsurf $84.75Inqovi $84.75Retevmo $83.09Piqray $82.40Padcev $77.33Ninlaro $76.57Fruzaqla $76.27Zejula $74.41Jemperli $74.41Ultomiris $74.22Pyrukynd $74.02Qinlock $73.29Lorbrena $71.82Stivarga $71.40Inlyta $65.44Enjaymo $64.60Elrexfio $64.10Provenge $63.29Yescarta $62.75Brukinsa $61.03Ruconest $60.38Rybelsus $57.15Tecvayli $54.51Elahere $53.29Orserdu $52.40Ontruzant $52.10Besponsa $51.17Bosulif $51.17Alecensa $50.04Rozlytrek $50.04Romvimza $45.78Tecentriq $41.68Wayrilz $41.29Blenrep $41.22Vitrakvi $39.52Monjuvi $38.53Adcetris $38.02Krazati $37.36Amtagvi $36.95Kyprolis $36.80Blincyto $36.80
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shannon Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.